Dysregulation of the gut microbiota and barrier impairment during hypertension induces chronic translocation of lipopolysaccharide (LPS) into circulation, causing an imbalance of NOX and antioxidant enzymes through toll-like receptor 4 (TLR4). This evidence concerns the gene TLR4 and hypertensive disorder.